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VOLUNTARY LABELING OF BIOENGINEERED FOOD:
COGNITIVE DISSONANCE IN THE LAW,
SCIENCE, AND PUBLIC POLICY
Frank J. Miskiel
It has become commonplace-the norm-for government regulation to
seem completely detached from comnmon sense. So much so that regulation
typically imposes enormous costs-in terms of money, time, and inconven-
ience-on American consumers, businesses, and employees, with very lit-
tle benefit, if any.'
I. INTRODUCTION
"Non-GMO." This is a label that has recently begun to appear on many
foods in the United States. Now the "non-GMO" segment of the food indus-
try is vying with the "organic" food industry's growing popularity.2 "GMO"
is an acronym for "genetically modified organisms" and has been embraced
as shorthand for all bioengineered foods.' The "non-GMO" label itself has
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1. JAMEs T. BENNETT & THOMAS J. DiLORE"'zo. TIlE FOOD & DRINK POUCE-
AMEIcA's NANNIES, BUSYBODIES & PETTY TYRANTS 17 (1999) (commenting generally on
PHILn HowARD, THE DEATH OF COMMON SENSE: How LAw is SuiTTCAUNG AMERIcA
(1994)).
2. See Seeds of Doubt: Some Ingredients are Genetically Modified, Despite Labels.
WALL ST. J., Apr. 5, 2001, at A1, available at 2001 WL 2859401. The organic foods segment
of the industry is currently a $7.8 billion market, and while the packaged foods segment is
growing at a rate of about 2.6% per year, the organic foods segment is growing at eight times
that rate. Id. at *3. "Organic" foods are those that are in compliance with the USDA guide-
lines for certified organic food, which requires that the food must be cultivated without the
use of sewage sludge, synthetic chemical fertilizers, pesticides, herbicides, growth hormones.
radiation, or genetically modified organisms. USDA National Organic Program. 65 Fed. Reg.
80548-01 (2000). For a good overview of the controversy defining "organic," see Cindy
Hyman, Food for Thought: Defending the Organic Foods Production Act of 1990 Against
Claims of Protectionism, 14 EMORY INT'L L. REv. 1719,1725-37 (2000).
3. These are foods that have been genetically altered through the use of recombinant de-
oxyribonucleic acid [rDNA] technology. Other euphemisms for such products include geneti-
cally modified foods, genetically engineered foods, and even Frankenstein foods. One prob-
lem with using the GMO acronym is that most bioengineered food contains no genetically
1
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certain connotations. First, "non-GMO" is intended to denote that the prod-
uct contains no genetically modified material. Yet recent studies have sug-
gested that some foods labeled as "non-GMO" actually contain as much as
forty percent genetically altered ingredients.' Second, the "non-GMO" label
implies that something bad, unhealthy, or undesirable is not present. Scien-
tific evidence shows that bioengineered food ingredients are not materially
different from the non-engineered versions.' Given that no material differ-
ence has been shown between "GMO" and "non-GMO" foods, the presence
of "GMO" ingredients in a food should not alter its safety. But the U.S. Food
and Drug Administration (FDA)6 is now giving serious consideration to al-
lowing labeling of "non-GMO" food. Consider this label:
"'This food is free from miniscule, unidentified insect fragments and ro-
dent hair."
Even though a food might bear this label, the food may actually contain
these contaminants. Why? The government has determined that small quan-
tities of these contaminants are not excludable in the manufacturing process
and that small quantities of contamination are a "trifle,"7 making such a label
modified organisms.
4. See Seeds of Doubt: Some Ingredients are Genetically Modified, Despite Labels, supra
note 2, at * I ("A laboratory test conducted for the Wall Street Journal showed that about 40%
of the soybean DNA detected in a sample [of Veggie bacon] came from genetically modified
plants.").
5. See Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have
or Have Not Been Developed Using Bioengineering; Availability, 66 Fed. Reg. 4839 (Jan. 18.
2001) (where the FDA suggested that material differences would include changes which are
significantly different, which would make the common or usual name insufficient to ade-
quately describe the new product, or if its nutritional properties are altered, or if it may con-
tain an allergen). For comparative discourses on the subject, see generally K. A. Goldman,
Genetic Technologies. Bioengineered Food-Safety and Labeling, 290 SCIENCE 457 (2000):
Henry I. Miller, A Rational Approach to Labeling Biotech-Derived Foods, 284 SCIENCE 1471
(1999); D. A. Kessler et al., The Safety of Foods Developed by Biotechnology, 256 SCIENCE
1747 (1992); H. J. Atkinson et al., The Case for Genetically Modified Crops Witi a Poverty
Focus, 19 TRENDS BIOTECHNOL. 91 (2001); C. N. Stewart, Jr. et al., Transgenic Plants and
Biosafety: Science, Misconceptions and Public Perceptions, 29 BIOTECHNiQtuJs 832 (2000);
and M. A. Martens, Safety Evaluations of Genetically Modified Foods, 73 (Suppl.) IN1.
ARCH. OCUP. ENVIRON. HEALTH S 14 (2000).
6. See ERIC D. HIRSCH, DICTIONARY OF CULTURAL LITERACY 510 (2d ed. 1993) (explain-
ing that the Food and Drug Administration is an agency of the federal government in the ex-
ecutive branch that monitors the introduction of new foods or drugs and is responsible for the
safety of food and drugs in American commerce).
7. U.S. v. Capital City Foods, Inc., 345 F. Supp. 277, 279 (D.N.D. 1972). One significant
problem raised in this case was that the Food and Drug Administration had set no standard for
allowable foreign matter. In its "Notice of Proposed Rule Making on Natural or Unavoidable
Defects in Food for Human Use that Present No Heath Hazard," published in the Federal Reg-
ister Vol. 37, 3/30/1972, the FDA concluded "[flew foods contain no natural or unavoidable
defects. Even with modem technology, all defects in foods cannot be eliminated. Foreign ma-
terial cannot be wholly processed out of foods, and many contaminants introduced into foods
through the environment can be reduced only by reducing their occurrence in the environ-
ment." A food manufacturer has to reduce any contamination only to the lowest level cur-
rently feasible (Action Levels for Added Poisonous or Deleterious Substances in Food. 55
[Vol. 38
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unnecessary. What distinction is the government making about food that
would justify a "non-GMO" label while not condoning a label on food con-
taminated with insect parts and rodent hair? The absence of material shown
to be essentially equivalent to "normal" food can be labeled while the pres-
ence of contaminants can not? This smacks of cognitive dissonance.'
In January 2001, the FDA issued a "Draft Guidance for Industry: Vol-
untary Labeling Indicating Whether Foods Have or Have Not Been Devel-
oped Using Bioengineering" (2001 Draft Guidance).' The FDA is soliciting
input from those concerned in an effort to formulate effective guidelines for
labeling bioengineered foods. But what is the impetus behind this apparent
proactive move by the FDA? Consumer interest groups want mandatory la-
beling of all bioengineered foods.'" The FDA and the U.S. courts have con-
sistently said that mandatory labeling will not be required for GMO or bio-
engineered foods." So, the groups are using an alternate strategy to achieve
essentially the result they desire. By pressuring the FDA to establish guide-
lines on the labeling of wn-GMO foods, manufacturers will now have a le-
gal way of labeling their products as "non-GMO," and will do so to achieve
a marketing advantage. Foods that do contain GMOs that cannot meet the to-
Fed. Reg. 20785, May 21, 1990). 21 C.F.R. § 109 contains regulations regarding "unavoid-
able contaminants in food for human consumption." Even though insect fragments are con-
sidered "filth" and therefore a violation of 21 U.S.C. § 342 (see Golden Grain Macaroni Co.
v. U.S., 209 F.2d 166, 167-68 (9t Cir. 1953)), unless the FDA has promulgated some standard
of contamination, and if there is no evidence that the contamination could have been avoided
during manufacture, then it does not constitute an "adulteration" of the food.
8. Cognitive Dissonance Theory was developed in 1957 by Leon Festinger. Cognitive
Dissonance is said to result when an individual holds as true two beliefs that are contradictory
to each other. See Leon Festinger, Cognitive Dissonance, available at
http://tip.psychology.orglfestinge.html. "Dissonance can be eliminated by reducing the impor-
tance of the conflicting beliefs, acquiring new beliefs that change the balance, or removing the
conflicting attitude or behavior. Id. For a more detailed review of this subject, see generally
Cognitive Dissonance, available at http://www.ithaca.edu/faculty/sephens/cdback.html.
9. Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or
Have Not Been Developed Using Bioengineering; Availability, 66 Fed. Reg. 4839 (Jan. 18.
2001). Although the original comment period was set to expire after 75 days of publication in
the Federal Register, requests for additional time to submit comments were allowed and the
deadline was extended until May 3, 2001. See Premarket Notice Concerning Bioengineered
Foods; Extension of Comment Period, 66 Fed. Reg. 17517 (Apr. 2, 2001).
10. These groups include the Center for Food Safety, Friends of the Earth, the Public In-
terest Research Groups, and Greenpeace. See Steve Lash, Industry Gives Qualified Support
for Voluntary Labeling (Food Industry Follows FDA s Standards for Genetically Modified
Foods), 43(7) FOOD CHEMICAL NEWs, Apr. 2, 2001, available at 2001 WL 12772928. at *1.
See also, Seeds of Doubt: Some Ingredients are Genetically Modified, Despite Labels. supra
note 2, at *4. The involvement of public interest groups in the debate will be discussed in
more detail in Section IIIB, infra.
11. See, e.g., Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed.
Reg. 22984 (May 29, 1992); Draft Guidance for Industry: Voluntary Labeling Indicating
Whether Foods Have or Have Not Been Developed Using Bioengineering; Availability, 66
Fed. Reg. 4839 (Jan. 18, 2001); International Dairy Foods Ass'n v. Amestoy, 92 F.3d 67 (2d
Cir. 1996); and Alliance for Bio-Integrity v. Shalala, 116 F. Supp. 2d 166 (D.D.C. 2000). This
will be developed in more detail in the sections that follow below.
2001]
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to-be-established guidelines will not be able to utilize the "non-GMO" label.
By implication, these foods will be constructively labeled as being bioengi-
neered. The latent problems with this approach manifest themselves when all
the potentially genetically modified ingredients in a packaged food are con-
sidered. Will all ingredients need to be free from genetically altered mate-
rial? What standard will be used to determine "non-GMO"? And what con-
sequences does the "non-GMO" label have on the American food supply and
on the consumer?
What is the purpose of labels on food products? And to what extent
should the federal government become involved in regulating the labeling of
food products anyway? For nearly a century, the federal government has
carefully policed what creative entrepreneurs have attempted to place on
food labels to attract consumers. Under the auspices of the Foods and Drugs
Act of 1906,"2 Congress had the authority to prevent the sale of any food
product that was labeled in a false or misleading manner." Congress created
the Food and Drug Administration (FDA) in 1931 as an executive agency
dedicated to protecting the national health." Thus, from its inception, the
FDA has taken a keen interest in what manufacturers voluntarily place on
food labels.
Until the 2001 Draft Guidance 5 was issued in January 2001, the FDA
relied on the 1992 "Statement of Policy: Foods Derived from New Plant Va-
rieties" (1992 Policy),'6 which does not require any special labeling of bio-
engineered foods as a class of foods. 7 Under the 2001 Draft Guidance, the
FDA reaffirmed its decision not to require labeling of foods containing ge-
netically modified material. The FDA based its decision on scientific evi-
dence that bioengineered food ingredients are not materially different from
the non-engineered versions. 8 Mandatory labeling may be "scientifically
12. 1906 Federal Food and Drugs Act, Pub. L. No. 59-384, 34 Stat. 768 (1906) (codified
at 21 U.S.C. §§ 1-15 (1934) (repealed in 1938 by 21 U.S.C. § 392(a)).
13. Id. at 772.
14. See NEw YORK TixEs ALMANAC 2000 147 (John W. Wright, ed. 2000). The Food
and Drug Administration was formed when the Agriculture Appropriation Act of 1931 be-
came law, and was reorganized in November 1995 as part of the Health and Human Services
Department. Id.
15. Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or
Have Not Been Developed Using Bioengineering; Availability, 66 Fed. Reg. 4839 (Jan. 18,
2001).
16. Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed Reg. 22984
(May 29, 1992).
17. Id.
18. See Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have
or Have Not Been Developed Using Bioengineenng; Availability, 66 Fed. Reg. 4839 (Jan. 18.
2001) (where the FDA suggested that material differences would only include those changes
that make the food so significantly different that the common or usual name no longer ade-
quately describes the new product, or alters its nutritional properties. or introduces an unex-
pected allergen). For more detailed insight into the rationale used by the FDA, and comments
made by Jane E. Henney, M.D., an FDA Commissioner, see generally, Larry Thompson, Are
Bioengineered Foods Safe?, 34 FDA CONSUMER 1 (2000).
[Vol. 38
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unwarranted" and face "significant legal impediments."' 9 Specifically, man-
datory labeling of bioengineered foods may constitute a violation of the
manufacturer's First Amendment right not to speak? Strong consumer con-
cern alone is not sufficient to justify mandatory labeling. :' The FDA is with-
out authority to mandate labeling without first determining that bioengi-
neered food as a class poses inherent risks to consumers." Moreover, the
courts have affirmed the FDA's decisions to accord bioengineered foods a
presumption of "generally recognized as safe" (GRAS) status' and to not
mandate labeling of genetically engineered foods.'
The FDA's policy is in stark contrast to the situation in Europe. Since
1998, the European Union (EU) has required labeling of all foods that con-
tain genetically modified organisms.' In January 2000, the Commission of
the European Communities (CEC) issued labeling directives for bioengi-
neered foods, and established a tolerance level for adventitious "contamina-
tion" of non-bioengineered food by rDNA or recombinant protein. :6
Although the debate on the issue of mandatory labeling for bioengi-
neered foods continues in the United States,"' there may be legitimate rea-
19. Karen A. Goldman, Labeling of Genetically Modified Foods: Legal and Scientific
Issues, 12 GEo. INT'L ENvTL. L. REv. 717, 718 (2000).
20. International Dairy Foods Ass'n v. Amestoy, 92 F.3d 67, 72 (2d Cir. 1996).
21. Id. at 73-74.
22. Alliance for Bio-Integrity v. Shalala, 116 F. Supp. 2d 166, 179 n.8 (D.D.C. 2000),
23. Id. at 178.
24. Id. at 179.
25. See generally Council Directive 90/220/EEC of 23 April 1990 on the deliberate re-
lease into the environment of genetically modified organisms, Document 390L0220, Official
Journal L 117, 08105/1990, at 15-27 (1990), available at http.//europaeu.intleur-
lex/en/lif/dat/1990/en_390L0220.html; and Council Regulation (EC) No. 1139198 concerning
the compulsory indication on the labeling of certain foodstuffs produced from genetically
modified organisms of particulars other than those provided for in Directive 79/112/EEC, Of-
ficial Journal L 244, 03/09/1998, at 20 (1998).
26. Commission Regulation (EC) No. 49/2000 of 10 January 2000 amending Council
Regulation (EC) No. 1139198 concerning the compulsory indication on the labeling of certain
foodstuffs produced from genetically modified organisms of particulars other than those pro-
vided for in Directive 79/112/EEC, Document 300R0049, Official Journal L 006. 11/01/2000
pp. 13-14.
27. Depending on who is conducting the survey, Americans either want or do not want
labeling of all bioengineered food. Compare Joan Murphy, IFIC Survey Shows Support for
Labeling All Bioengineered Foods, 43 Food Chemical News, * 1 (2001) available at 2001 WL
12772710 (where various polls revealed contrasting results regarding whether Americans
wanted to know about the presence of bioengineered foods), with Seeds of Doubt: Some In-
gredients are Genetically Modified, Despite Labels, supra note 2, at *4 (where a January 2001
survey found that "75% of respondents wanted to know about the presence of genetically
modified ingredients in food and 58% opposed such ingredients."). In a May 2000 poll, 52%
of Americans favored the FDA position that labeling bioengineered foods was unnecessary.
Murphy, supra, at *4. However, after the discovery of StarLinkTI corn in taco shells, that
stance shifted with 58% of Americans polled in favor of labeling all bioengineered food. Id.
But in a different survey, when asked what information is missing from food labels, 74% re-
sponded "nothing" and only 2% said "genetically altered" ingredients. Id. Further. 64%
"voiced continued support for the use of genetically engineered foods." Id. For some insight
2001]
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sons for allowing voluntary labeling of bioengineered food products." For
instance, manufacturers may be under pressure from the global market to
identify whether their products contain any bioengineered material.29 Other
groups see the "non-GMO" label as a way of capturing a certain (and grow-
ing) segment of consumers." In issuing the 2001 Draft Guidance, the FDA is
proactively assisting manufacturers with guidelines to ensure that they do
not make any false or misleading statements on their voluntary labels.
Most of the world's existing regulations deal with only popular geneti-
cally modified plants, such as corn and soybeans." Labeling bioengineered
products themselves, like the Flavr SavrTM tomato or products predominately
corn- or soy-based, makes intuitive sense. What these regulations do not ad-
dress is how labeling laws should be applied to certain food ingredients,
such as flavors or thickeners,3" or to process ingredients such as yeast or en-
zymes,33 present in very small quantities in many prepared foods."4 The
FDA's 1992 policy only addresses genetically engineered plants, while mi-
croorganisms (that may or may not have been genetically modified) produce
as to why some Americans want labeling, see, e.g., Politics & Policy-Genetically Modified
Food: Consumers Want Labels, Am. Pol. Network, 6 Am. Health Line, *1 (2001), available
at Westlaw, APN-HE 10, and Bill Radford, Allergies Prompt Fears of Bioengineering, New-
ark, N.J. Star-Ledger, Apr. 25, 2001, available at 2001 WL 19749740.
28. See Lash, supra note 10, at *1. Although continuing to oppose mandatory labeling of
bioengineered food, the food industry groups told the FDA that they would tentatively support
voluntary labeling, but even voluntary labeling "could needlessly alarm consumers or lead
them to think erroneously that they should beware of genetically modified foods - Id. For an
economic approach to food labeling, see generally Elise Golan, Economics of Food Labeling.
Economic Research Service, U.S. Department of Agriculture, Agricultural Economic Report
No. 793 (2000), available at http://www.ers.usda.gov/publications/aer793.
29. See generally Michael A. Whittaker, Reevaluating the Food and Drug Administra-
tion's Stand on Labeling Genetically Engineered Foods, 35 SAN DIEGO L. RIV. 1215, 1231-
35 (1998).
30. See Seeds of Doubt: Some Ingredients are Genetically Modified, Despite Labels, su
pra note 2.
31. See Kathryn Brown, Seeds of Concern, SCIENTIFIC AMERICAN, Vol. 284, No. 4, April
2001, at 56. The domnant bioengineered food crops for 2000 were soybeans, corn. and ca-
nola. Additionally, bioengineered versions of potatoes, squash, papayas, melons, and tonia-
toes have also been introduced into the marketplace, but are dwarfed in comparison to the
dominant three.
32. LARRY SYNDER & WENDY CIIAMPNESS, MOIECULAR GENETICS Of BA"IERIA 449
(1997). For example, xanthan gum, which is ubiquitous in prepared foods, is a polysaccharide
produced commercially by fermentation of Xanthomonas campestris. Id.
33. P. C. WINTER ET AL., INSTANr NoTEs IN GENErICs 322, Table 2 (Andrea Bosher, ed.,
1998). For example, recombinant enzymes have been utilized for cheese manufacture (rennin
and lipase), beer production (ca-amylase), alcohol and glucose production (cellulase), meat
tenderizing (bromelain), and as antioxidants in food (catalase). Id.
34. See Elizabeth A. Yetley, Energy for a New Millennium-Regulatory Perspectives.
59(1) Nutrition Reviews (2001), available at 2001 WL 18219216. "Historically. food addi-
tives were used in small amounts to achieve technical effects such as color and low-calorie
sweetness. A multifold margin between estimated consumption levels associated with the
technical effect and possible adverse effects was used to establish safety." Id. at *3.
[Vol. 38
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some of these food additives." And even where genetically modified organ-
isms were not employed to manufacture the ingredients, genetically engi-
neered products such as corn or soybeans may have been utilized in their
production.36 This article addresses whether the use of these food additives
should subject the food products containing them to bioengineered food la-
beling requirements, and argues for not requiring labeling of these ingredi-
ents or the foods that contain them. The low use levels of these food addi-
tives result in a miniscule contribution of genetically modified material, and
regulations for "organic" foods already exist which would address the bio-
engineered food labeling issue.
Section H" of this article will address the existing regulations and poli-
cies that deal with foods produced using biotechnology, as well as the au-
thority under which the FDA acts to regulate food labeling. Section III as-
sesses the rationale for labeling bioengineered food, with a focus on the
consumer, evaluating the fears and concerns expressed regarding this tech-
nology. Section IV considers the ramifications of labeling with respect to
food additives, such as flavor or texture modifiers, that have not been ad-
dressed in the Draft Guidance. Finally, Section V explores how the volun-
tary labeling of bioengineered foods may potentially create mischief and
confusion. Without appropriate guidance and constraint, these labels may
confound any education of the consumer or protection of the safety of the
food supply.
35. Statement of Policy: Foods Derived From New Plant Varieties. 57 Fed. Reg. 22984
(May 29, 1992). The specific scope of the policy was delineated as follows:
This notice discusses scientific and regulatory considerations for foods derived
from new plant varieties. This notice does not address foods and food ingredients
regulated by FDA that have been derived from algae, microorganisms, and othcr
non-plant organisms, including: (I) foods produced by fermentation, where micro-
organisms are essential components of the food (e.g., yogurt and single cell pro-
tein); (2) food ingredients produced by fermentation, such as many enzymes, fla-
vors, amino acids, sweeteners, thickeners, antioxidants, preservatives, colors, and
other substances; (3) substances produced by new plant varieties whose purpose is
to color food; and (4) foods derived from animals that are subject to FDA's author-
ity, including seafood.
Id.
36. For example, the bacteria Xanthomnonas campestris is employed to produce xanthan
gum by growing in a fermentation medium that may contain cornstarch or corn syrup as a
carbon source and soybean hydrolysates as a nitrogen source. See U. S. Patent 4,696,900 (is-
sued September 29, 1987), Ellwood et al., Production of Bacterial Polysaccharides, col. 1.
lines 13-25; also see generally Letisse et al., Kinetic analysis of growth and xanthan gum
production with Xanthonanas campestris on sucrose, using sequentially consumed nitrogen
sources, 55 Applied Microbiology and Biotechnology 417 (200 1).
2001]
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II. FOOD LABELING REGULATIONS
A. Statutory Authority
Originally, the FDA regulated manufacturers' voluntary claims on food
labels to protect consumers. 7 Eventually, the FDA imposed mandatory
labeling requirements on food products. Currently the FDA requires a
number of elements on food labels to avoid misbranding: (I) the name and
address of the manufacturer, packer, or distributor; (2) the precise name of
the food; (3) a list of the ingredients used to manufacture the article,
including artificial flavoring, coloring, or preservatives, if used; (4) a
declaration of the net weight of the contents of the food; and (5) complete
nutritional labeling. 8 Section 403 of the Federal Food, Drug, and Cosmetic
Act (FFDCA) authorizes the FDA to regulate food labels.39 Under Section
343(a), a food is misbranded if its label is false or misleading.'" The FDA
defines misleading in the Act.4 ' It states that labeling is misleading if it fails
to reveal material facts in light of the representations made or suggested in
the labeling. In addition, it must reveal facts that are material with respect to
consequences resulting from customary or usual conditions of use. Section
343(i) of the Act requires that each food bear a common or usual name or, in
the absence of such a name, an appropriately descriptive term."2 If the food is
manufactured by the combination of two or more ingredients, the common
or usual name of each ingredient must appear on the label. 3
Some voluntary labeling of foods is already subject to regulation. Regu-
lations currently exist for foods that make health claims. Foods subject to
these regulations include foods that claim the ability to lower cholesterol us-
ing soluble fiber" or plant sterols or stanol esters,' or foods, which allow the
37. 1906 Federal Food and Drugs Act, Pub. L. No. 59-384, 34 Stat. 768 (1906) (codified
at 21 U.S.C. §§ 1-15 (1934) (repealed in 1938 by 21 U.S.C. § 392(a)).
38. See Federal Food, Drug, and Cosmetic Act (FFDCA), 21 U.S.C. 343(c). (g), (i). (k).
and (m) (2001); and see generally Nutrition Labeling and Education Act of 1990 (NLEA).
Pub. L. No. 101-535, 104 Stat. 2353 (codified at 21 U.S.C. §§ 301 et seq. (2001).
39. See Federal Food, Drug, and Cosmetic Act of 1938, Pub. L. 75-717, 52 Stat. 1040
(1938) (codified as amended at 21 U.S.C. §§ 301 et seq. (2001).
40. See 21 U.S.C. § 343(a) (2001).
41. 21 U.S.C. § 321 (n) (2001).
42. See 21 U.S.C. § 343(i)(1) (2001).
43. See 21 U.S.C. § 343(i)(2) (2001).
44. See Food Labeling: Health Claims; Soluble Fiber From Certain Foods and Coronary
Heart Disease, 21 C.F.R. pt. 101, 63 Fed. Reg. 8103-01 (1998) and Food Labeling: Health
Claims and Label Statements; Dietary Fiber and Cardiovascular Disease, 58 Fed. Reg. 2552-
01(1993).
45. See Food Labeling: Health Claims; Plant Sterol/Stanol Esters and Coronary I leart
Disease, 65 Fed. Reg. 54686-01 (2000). These compounds have been claimed to reduce cho-
lesterol in the body when they are consumed on a regular basis. Plant sterols interfere with the
uptake of dietary and biliary cholesterol from the intestinal tract. See Heineman ct al., Mecha.
nisms of Action of Plant Sterols on Inhibition of Cholesterol Absorption. Comparison of Sito-
sterol and Sitostanol, 40 (supp. 1) EUR. J. CLINICAL PIIARMACOL. S59 (1991). Inclusion of
230 [Vol. 38
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consumer to effectuate diet modification, such as reduced fat' or sodium."
Regulations also make it possible for consumers to choose foods manufac-
tured in a certain way, such as organic foods." In addition, manufacturers are
required to warn consumers about adverse health risks of any ingredient in
the food. ' Moreover, the "Delaney Clause," enacted in 1958, mandates that
a food additive "shall be deemed unsafe [for food use] ... if it is found...
to induce cancer in man or animal."' Hence, most compounds that are found
to cause cancer in laboratory animals are prohibited for use in foods. The
FDA has attempted to create certain exceptions for de mininis risks using a
risk-utility analysis, but the courts' reactions have been mixed.' Foods that
contain allegedly carcinogenic ingredients must carry warning labels. An ex-
ample of an approved warning label that states the carcinogenic potential of
a food ingredient is the label that (until very recently) has been required on
foods containing saccharin.'
these compounds in the diet has been shown to have a hypocholesterolemic effect. See gener-
ally Tu T. Nguyen, The Cholesterol-Lowering Action of Plant Stanol Esters, 129 J. NtrrR.
2109 (1999) and Maarit A. Hallikainen et al., Plant Stanol Esters Affect Serum Cholesterol
Concentrations of Hypercholesterolemic Men and Women in a Dose-Dependent Manner, 130
J. NuT. 767 (2000). These compounds have been incorporated into margarine sold under the
brand name BenacolM or Take ControlTMI , and studies suggest that ingesting two grams of the
sterol or stanol esters on a daily basis can lower serum cholesterol. See Maarit A. Hallikainen
et al., Comparison of the Effects of Plant Sterol Ester and Plant Stanol Ester-Enriched Mar-
garines in Lowering Serum Cholesterol Concentrations in llyper-Cholesterolemic Subjects on
a Low-Fat Diet, 54 EUR. J. CLINICAL NUTR. 715 (2000).
46. See Food Labeling: Nutrient Content Claims Pertaining to the Available Fat Content
of Food, 61 Fed. Reg. 67243-01 (Dec. 20, 1996).
47. See Food Labeling: Declaration of Sodium Content of Foods and Label Claims for
Foods on the Basis of Sodium Content, 49 Fed. Reg. 15510 (Apr. 18, 1984).
48. The Federal Organic Foods Production Act of 1990. Pub. L. No. 101-624, 104 Stat.
3935 (codified at 7 U.S.C. § 6501 (1999) (the federal statutes that govern organic claims). See
also Program to Assess Organic Certifying Agencies, 64 Fed. Reg. 30,861, 30,862 (1999).
The USDA adopted national standards for organic foods on 12/21/2000 (USDA National Or-
ganic Program, 65 Fed .Reg. 80548-01 (2000)).
49. 21 U.S.C. § 321(n). Examples of such warning labels are those found on products
that contain aspartame (due to the phenylalanine component and the potential risk to
phenylketonurics) or products that contain peanuts or other nut products (due to the severe
allergic reaction a small segment of society has to certain nut proteins).
50. 21 U.S.C. § 376(b)(5)(B) (1982).
51. See, e.g., Public Citizen v. Young, 831 F.2d 1108 (D.C. Cir. 1987) (overturmng the
FDA's approval of Orange Dye No. 17 where the risk of cancer was determined to be less
than one in 19 billion); Simpson v. Young, 854 F.2d 1429 (D.C. Cir 1988) (affirming the
FDA's approval of Blue Dye No. 2, deferring to the FDA's interpretation of carcinogenic test-
ing data); and Monsanto Co. v. Kennedy, 613 F.2d 947 (D.C. Cir. 1979) (allowing the pres-
ence of acrylonitrile, a carcinogenic material found in plastic food containers believed to mi-
grate into food).
52. See Consolidated Appropriations - FY 2001. Pub. L. 106-554, § l(a)(l) [Title V, §
517], 114 Stat. 2763, 2763A-73 (Dec. 21, 2000). In December 2000, Congress passed legisla-
tion, known as the SWEETEST Act, which stands for Saccharin Warning Elimination via En-
vironmental Testing Employing Science and Technology (see Introduction of H.R. 5668. Sac-
charin Warning Elimination via Environmental Testing Employing Science and Technology,
146 Cong. Rec. E2237-01, available at 2000 WL 1847450 (Cong.Rec.)) that stated that the
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B. Misbranding: Misleading or Material?
The food label may be presented in creative shapes adorned with attrac-
tive colors or artwork, and is often the product of much marketing and ad-
vertising research. 3 From the manufacturer's perspective, the label is used
more to attract consumers and promote a sale than to inform the consumer.
It is probably the regulatory scheme, evolved over the last century, which
has led to a careful balance between the hype and hubris of marketing and
the public policy requirements of consumer information and education. One
way in which the federal government has crafted this balance is to monitor
labels to ensure that they do not misbrand the product. To determine whether
a food is misbranded, the FDA reviews statements and claims on food labels.
The FDA may declare the food misbranded if the label is false or misleading
in any way." Both the presence and the absence of information are relevant
to whether the label is misleading. 6 Generally, misleading refers to the fail-
ure to reveal material facts that the consumer needs to know about the food."
Although it would be easy to determine whether the container's actual
weight comports with the stated weight, or that it contains the ingredients
claimed on the label, some claims may require further substantiation in order
to be considered truthful. An example is the purported ability of oatmeal
consumption to remove cholesterol. 8 Many scientific studies have been con-
warning label is no longer required. The warning label on a package of Sweet 'N Lowr'I.
which is a product of Cumberland Packaging Company, formerly read, "Use of this product
may be hazardous to your health. This product contains saccharin, which has been determined
to cause cancer in laboratory animals." Although most companies would deplete their existing
inventory of packaging materials before making labeling changes, these warning labels
quickly disappeared due to the resulting positive marketing impact of the removal of this
warning.
53. Fred H. Degnan, Biotechnology and the Food Label: A Legal Perspective, 55 Food &
Drug L.J. 301, 301 (2000) (contending that "the food label inspires and provides the critical
stimulus for a food purchase" and that the label "is the front line of product marketing and,
thus, subject to fundamental yet idiosyncratic decisions as to what information, art work.
form, and level of taste will attract consumer attention and induce a purchase.").
54. Id. at 310. Manufacturers generally include information on the label to promote the
product, but may voluntarily include information to respond to consumer demand or desire for
additional information.
55. 21 U.S.C § 343(a) (2001).
56. 21 U.S.C. § 321(n) (2001).
57. American Frozen Food Inst. v. Mathews, 413 F. Supp. 548, 554 (DCDC 1976) af
firmed 555 F.2d 1059, 181 U.S.App.D.C. 122 (1977). See also 21 CFR 102.5(b) (2001). Ali
example would be whether the food contains any peanuts, either as an intended ingredient or
adventitiously introduced during manufacture. Individuals allergic to peanuts face life-
threatening allergic responses if subjected to even minute quantities of the peanut protein re-
sponsible for their allergic reaction. Failure to warn of potential peanut protein components in
the food would be a misleading label, since it falsely leads a consumer to believe that the food
contains no peanut products.
58. On a recently purchased 42-ounce package of Quaker Oats, manufactured by the
Quaker Oats Company, the claim "Oatmeal Helps Reduce Cholesterol" appears twice on the
package in large, bold type, accompanied by an even larger red heart. Further, the following
[Vol. 38
10
California Western Law Review, Vol. 38 [2001], No. 1, Art. 6
https://scholarlycommons.law.cwsl.edu/cwlr/vol38/iss1/6
VOLUNTARY LABELING OF BIOENGINEERED FOOD
ducted which suggest that including soluble fiber in a diet low in saturated
fat and cholesterol may reduce the risk of heart disease.' Without this evi-
dence to support these claims, this labeling would be false, not just mislead-
ing.
Information on the label does not have to be false to be misleading. One
example is the use of the words low fat or reduced fat on some food labels.
The foods may be lower in total fat content, but that does not always mean
that they have fewer calories.' The caloric content of many of these products
is the same (or sometimes higher) than the full fat alternative.6' Another ex-
ample is the claim that a particular juice product contains 100% juice.' In
actuality, the product is 100% juice, but the consumer purchasing cranberry
juice with such a label expects to get 100% cranberry juice, not a blend of
cranberry and apple juices. 3 In terms of regulations, however, "misleading"
appears on the back of the package: "You know that oatmeal helps reduce cholesterol. But do
you know how? Eating a good-sized bowl of Quaker Oatmeal for 30 days will actually M
move cholesterol from your body. Think of oats simply as tiny sponges that soak up choles-
terol and carry it away. And this simple lifestyle change can make a big difference in the
health of your heart." (A literal reading of this advertisement begs the question, Why would
one want to eat a single good-sized bowl of oatmeal over the course of thirty days?) Further in
the ad, in the cooking directions for 1, 2, and 3 servings, the number 2 is replaced by a red
heart with an arrow indicating that this serving size provides 3 grams of soluble fiber,
suggesting that this is the "good-sized" bowl they recommend.
59. See generally Michael H. Davidson et al., The Hypocholesterolemic Effects of Beta-
Glucan in Oatmeal and Oat Bran. A Dose-Controlled Study, 266 JAMA 1079 (1991) (spon-
sored by Quaker Oats Company); R. W. Kirby et al.. Oat Bran Intake Selectively Lowers Se-
rum Low-Density Lipoprotein in Cholesterol Concentrations of Hypercholesterolemic Men.
34 AM. J. CLINICAL NuTR. 824 (1981); L. Van Horn et al., Serum Lipid Response to Oat
Product Intake with a Fa-Modified Diet, 86 J. AM. DIET Ass'N 759 (1986); J. F. Swain et al.,
Comparison of the Effects of Oat Bran and Low-Fiber Wheat on Serunm Lipoprotein Levels
and Blood Pressure, 322 NEw ENG. J. MED. 147 (1990); P. A. Judd & A. S. Truswell. The
Effect of Robed Oats on Blood Lipids and Fecal Steroid Excretion in Man, 34 A.Mt. J.
CLINICAL NUTR. 2061 (1981); and L. Van Horn et al., Effects of Serun Lipids of Adding In-
stant Oats to a Usual American Diet, 81 AM. J. PUB. HEALTH 183 (1991).
60. See CHI. TRm., Jan. 11, 2001, Evening Health, at 7, available at 2001 WL 4029404.
which states that these terms have become a "marketing gimmick" to sell the product, and the
fat is often replaced with other high-calorie ingredients.
61. See Lawrence Lindner, Eating Right: The Truth About Food "Facts"--Common Nu-
trition Notions Aren't Always Based on Reality, WASH. POST, Jan. 18. 2000, Health Section
(providing a few interesting comparisons of fat free or reduced fat food products to their full
fat versions. As examples, Smucker's fat-free butterscotch topping has the same caloric con-
tent as the full fat version, as does the reduced-fat version of Jif peanut butter. Similarly, the
reduced-fat version of Drake's chocolate Yodels has more calories than the full-fat version.).
62. See Marian Burros, Chugging Juice Can Mean Guzzling Sugar, MILWAUKEE
JOURNAL SEmTNEL, Aug. 30, 2000, Food Section (suggesting that many fruit juice products
are no more nutritious than soft drinks, and that the type of juice used is just as important as
the amount it contains. "All juices are not created equal. If the first ingredient is apple, grape,
or pear juice, there is no nutritional bang for the buck.").
63. See Mott's To Change Some Juice Labels, THE FOOD INST. REP., Aug. 7, 2000. at "2,
available at 2000 WL 24466199. After complaints from and an investigation by the NY At-
tomey General, Mott's, a leading producer of fruit juices, agreed to change its labeling prac-
tices which the Attorney General suggested was misleading although technically in compli-
ance with FDA labeling requirements. Id. The labels on Mott's juice products say "100%
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generally is confined to failing to reveal material facts about the food prod-
uct. According to the 2001 Draft Guidance:
Historically, the agency has generally interpreted that scope of the materi-
ality concept to mean information about the attributes of the food itself.
FDA has required special labeling on the basis of it being "material" in-
formation in cases where the absence of such information may: 1) pose
special health or environmental risks (e.g., warning statement on protein
products used in very low calorie diets); 2) mislead the consumer in light
of other statements made on the label (e.g., requirement for quantitative
nutrient information when certain nutrient content claims are made about a
product); or 3) in cases where a consumer may assume that a food, be-
cause of its similarity to another food, has nutritional, organoleptic, or
functional characteristics of the food it resembles when in fact it does not
(e.g., reduced fat margarine not suitable for frying).'
Following the above guidelines, there would be insufficient evidence to
support mandatory labeling of bioengineered foods. In general, products
produced by rDNA technology have been screened to ensure that they pose
no special health risks (although this is a hotly debated issue among propo-
nents of mandatory labeling). In the 2001 Draft Guidance, the FDA sug-
gested circumstances under which bioengineered foods would require label-
ing to conform to the dictates of Section 201(n) with regard to revelation of
the material facts about a food. These included:
1) if a bioengineered food is significantly different from its traditional
counterpart such that the common or usual name no longer adequately de-
scribes the new food, the name must be changed to describe the differ-
ence; 2) if an issue exists for the food or a constituent of the food regard-
ing how the food is used or consequences of its use, a statement must be
made on the label to describe the issue; 3) if a bioengineered food has a
significantly different nutritional property, its label must reflect the differ-
ence; and 4) if a new food includes an allergen that consumers would not
expect to be present based on the name of the food, the presence of that al-
lergen must be disclosed on the label.65
The FDA has indicated that no information has been supplied to it
which would allow it to "form the basis for concluding that... bioengineer-
ing [a food or food ingredient] is a material fact that must be disclosed under
sections 403(a) and 201(n)."'
Juice" with a picture of grapes or cherries and the fruits' names in large letters directly below.
even though the juice may be primarily apple juice blended with only portions of grape or
cherry juice to provide the designated flavor. It was asserted that this labeling could lead con-
sumers to falsely assume the product is 100% grape or cherry juice. Id.
64. Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or
Have Not Been Developed Using Bioengineering; Availability, 66 Fed. Reg. 4839 (Jan. 18.
2001).
65. Id.
66. Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or
Have Not Been Developed Using Bioengineering; Availability, 66 Fed. Reg. 4839, 4840
(2001).
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C. Case Law Regarding Labeling Genetically Modified Foods
This decision by the FDA not to require mandatory labeling for bioen-
gineered foods has some support in recent case law. One of the earliest cases
dealing with the issue of labeling bioengineered food was International
Dairy Foods Association v. Amestoy," which dealt with a Vermont regula-
tion requiring labeling of milk obtained from cows treated with recombinant
bovine somatotropin (bST).' The FDA had determined that dairy products
that came from treated cows were indistinguishable from products from un-
treated cows, and therefore declined to require any special labeling.' The
State of Vermont enacted a statute requiring milk produced by cows treated
with recombinant bST to be labeled as such" and imposed civil7 ' and crimi-
nal' penalties for failure to comply with the state law. The Second Circuit
determined that the law was unconstitutional in that it violated the manufac-
turers' First Amendment right not to speak."
In the recent case Alliance for Bio-Integrity v. Shalala," the lack of
mandatory labeling of bioengineered food was again at issue. In Alliance, a
coalition of consumer interest groups and consumers protested the FDA's
policy on bioengineered foods. They attacked the policy on a number of
grounds. They alleged the FDA's policy violated the Administrative Proce-
dure Act by not having a notice-and-comment period and that the FDA did
not provide an Environmental Assessment or Environmental Impact State-
ment. They also contended that the FDA's policy statement was arbitrary
and capricious under the "generally regarded as safe" (GRAS) requirements
of FFDCA, and that the FDA's failure to require labeling for bioengineered
food was arbitrary and capricious." In a Memorandum Opinion, the District
Court for the DC Circuit granted the defendant's-and denied the plain-
tiffs'-motion for summary judgment.
At issue was the 1992 "Statement of Policy: Foods Derived from New
Plant Varieties," in which the FDA announced that it would presume foods
produced using rDNA technology were GRAS under 21 U.S.C. § 321(s)
67. 92 F.3d 67 (2d Cir. 1996). For a thorough exploration of this case, see Goldman, su-
pra note 19, at 728-34.
68. Bovine somatotropin is a cow growth hormone naturally produced by cows. The re-
combinant version was produced by Genentech and licensed to Monsanto. Cows given sup-
plemental growth hormone produced more milk, and milk produced by cows so treated is in-
distinguishable from that produced by untreated cows, which is why the FDA declined to
require any labeling of products from cows treated with the supplemental hormone.
69. International Dairy Foods Ass'n v. Amestoy, 92 F.3d at 69.
70. VT. STAT. ANN. tit. 6, § 2754(c) (1994).
71. See Consumer Fraud Act, VT. STAT. ANN. tit. 9, ch. 63. §§ 2451 et seq. [Add. to Blue
Br. 12-13].
72. See Vt. Stat. Ann. tit. 6, ch. 151 (Supervision, Inspection and Licensing of Dairy Op-
erations), § 2671 et seq..
73. International Dairy Foods Ass'n v. Amestoy, 92 F.3d at 72.
74. 116 F. Supp. 2d 166 (D.D.C. 2000).
75. Id at 170.
2001]
13
Miskiel: Voluntary Labeling of Bioengineered Food: Cognitive Dissonance in
Published by CWSL Scholarly Commons, 2001
CALIFORNIA WESTERN LAW REVIEW
and, therefore, not subject to regulation as a food additive.76 The 1992 Policy
also indicated that bioengineering of food by rDNA modification was not a
"material fact" under 21 U.S.C. § 321(n), and that bioengineered foods did
not require special labeling." The district court held the 1992 Policy was a
policy statement and not a substantial rule; therefore, the 1992 Policy did not
come under the auspices of the Administrative Procedure Act, and the FDA
was not required to have a notice-and-comment period for this policy state-
ment."8 The district court also affirmed the position taken by the FDA in the
1992 Policy Statement itself that the Statement was not a major federal ac-
tion, and, therefore, the FDA was not required to provide an Environmental
Assessment or Environmental Impact Statement."
The plaintiffs challenged the FDA's decision not to require labeling of
bioengineered food. They asserted that bioengineered food should not be
presumed to be GRAS. They also argued that bioengineered food without a
label would be misbranded under 21 U.S.C. § 321(n). The court concluded
that the FDA's decision to accord bioengineered food a presumption of
GRAS status was neither arbitrary nor capricious." According to the court,
the FDA's decision was based on scientific data that recombinant proteins
are no different from proteins required for nutrition, and thus it was proper to
defer to the FDA's expertise in evaluating such scientific data.8'
The court then addressed the issue of misbranding. The plaintiffs al-
leged that the products containing bioengineered foods were misbranded be-
cause they failed to present "facts... material with respect to consequences
which may result from the use of the article to which the labeling... relates
under the conditions of use prescribed in the labeling.., or under such con-
ditions of use as are customary or usual."8 The statutory meaning of mate-
rial became the focal point, as the plaintiffs contended that whether the
foods contained bioengineered material was material to a wide section of the
consuming public, some religious groups, and to many people with food al-
lergies.83 The court opined that an executive agency's interpretation of a stat-
ute that it is charged with administering is afforded substantial deference,"
and that as long as the interpretation is reasonable, courts are reluctant to
impose judicial interpretation. 85
76. See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg.
22984 (1992).
77. Id. at 22991 (1992).
78. Alliance for Bio-Integrity v. Shalala, 116 F. Supp. 2d 166, 172-73 (D.D.C. 2000).
79. Id. at 174-75.
80. Id. at 177.
81. Id. (citing International Fabricare Institute v. U.S.E.P.A., 972 F.2d 384, 389
(D.C.Cir. 1992), which stated, "The rationale for deference is particularly strong when the
[agency] is evaluating scientific data within its technical expertise.").
82. 21 U.S.C. § 321(n).
83. Alliance for Bio-Integrity v. Shalala, 116 F. Supp. 2d at 178.
84. See Rust v. Sullivan, 500 U.S. 173, 184 (1991).
85. See Pauley v. Beth Energy Mines, Inc., 501 U.S. 680, 702 (1991) (concluding that
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The FDA concluded that foods produced using rDNA technology were
not materially different from other foods and therefore warranted no addi-
tional labeling. The court found that consumer interest alone was insufficient
to deem the use of rDNA technology in food production material for the
purposes of mandatory labeling." In addition, the court noted that the 1992
Policy already contained provisions requiring special warning statements on
labels where the FDA has identified an increased safety risk or a material
change in bioengineered foods.' The court concluded, "without a determina-
tion that, as a class, rDNA-derived foods pose inherent risks or safety conse-
quences to consumers, or differ in some material way from their traditional
counterparts, the FDA is without authority to mandate labeling."'u
III. THE RATIONALE BEHIND THE LABELING PROPOSAL
A. hiformed Consumer Choice
Although the courts have held that the FDA lacks authority to mandate
labeling of bioengineered foods, manufacturers are able to include informa-
tion on the label as long as it does not deceive the consumer and thus result
in misbranding. Manufacturers may wish to provide this information by in-
cluding whether or not their product utilized bioengineering technology.
Some consumers have expressed concern over bioengineered foods, citing
fears for both food safety and the environment." These consumers would be
the targeted market for labeled foods. In addition, legislation entitled The
Genetically Engineered Food Right-to-Know Act was introduced in Con-
gress in May 2000 to require labeling of bioengineered foods, and if enacted,
failure to label bioengineered food would result in the products being mis-
branded under the Federal Food, Drug, and Cosmetic Act.' To address these
issues, the FDA issued its Draft Guidance as a proactive step toward a co-
herent and workable voluntary labeling scheme.
But when one takes a close look at the rationale behind addressing con-
sumer concerns, it becomes evident that labeling may not create informed
consumers. The very purpose of the voluntary label needs to be addressed in
order to ascertain the public good that would be derived. Since some con-
sumers have stated that they choose to avoid bioengineered food altogether,
the interpretation does not have to be "the best or most natural by grammatical or other stan-
dards," but merely reasonable).
86. See Stauber v. Shalala, 895 F. Supp. 1178, 1193 (W.D. Wis. 1995) (holding that "in
absence of evidence of a material difference, the use of consumer demand as the rationale for
labeling would violate the Food, Drug, and Cosmetic Act").
87. Alliance for Bio-Integrity v. Shalala, 116 F. Supp. 2d at 179 n.8.
88. Id
89. See Matthew Franken, Fear of Frankenfoods: A Better Labeling Standard for Ge-
netically Modified Foods, 1 MiNN. IN'FELL. PROP. REV. 153. 158-59 (2000).
90. See S. 2080, 106th Cong. (2000) (introduced in the House as H.R. 3377. 106th Cong.
(1999)).
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it has been proposed that a general label such as "contains bioengineered in-
gredients" would be a cost-effective method of satisfying consumer interest.
But what such a label connotes is that there is some materially different at-
tribute between bioengineered ingredients and traditional ingredients, for
which there is scant supporting scientific evidence. In addition, such labeling
would suggest that traditional food is somehow superior to bioengineered
food, which would be disallowed.9' A further problem arises in determining
what quantity of bioengineered product in a food would make such a label
accurate. In the EU, the presence of any amount of genetically modified ma-
terial intentionally introduced into the food results in mandatory labeling,"
while adventitious introduction of less than one percent of genetically modi-
fied material would not require labeling.93 Further, it is not entirely clear ex-
actly what aspect of the food is to be quantified to determine whether it
should be regarded as a bioengineered food. When the dietary exposure of a
consumer to a novel protein produced using rDNA technology is calculated
for bioengineered canola oil compared to traditional canola oil, the total ex-
posure in one year is 0.0000094 grams or 9.4 micrograms." In addition, the
technology95 that allows detection of rDNA in products is not ubiquitous and
requires some sophistication for its application. In fact, the process for
rDNA detection needs a copy of the very same DNA sequence that is under
91. See Natalie Pargas, Next Generation Biotech Products Will Face Traditional Label-
ing Issues in U.S., Maryanski Notes, 40 FOODS CHEMICAL NEWS (Information Access Co)
No. 21 (July 13, 1998), available in Westlaw, 1998 WL 10981464; and Cliff D. Weston,
Chilling of the Corn: Agricultural Biotechnology in the Face of U.S. Patent Law, J. SMALL &
EMERGING Bus. L. 377, *38 (2000) where the author contends that the opponents to manda-
tory labeling present at the meeting "argued that singling out GM products would mark them
as different and, in the eyes of consumers bombarded with activist messages, paint them as
tainted and dangerous."
92. See generally Council Directive 90/220/EEC of 23 April 1990 on the deliberate re-
lease into the environment of genetically modified organisms, Document 390L0220, Official
Jounral L 117, 08/05/1990, pp. 15-27 (1990) available at http://europa.eu.inteur-
lex/en/lif/dat/1990/en_390L0220.html.
93. See generally Commission Regulation (EC) No. 49/2000 of 10 January 2000 amend-
ing Council Regulation (EC) No. 1139/98 concerning the compulsory indication on the label-
ing of certain foodstuffs produced from genetically modified organisms of particulars other
than those provided for in Directive 79/112/EEC, Document 300R0049, Official Journal L
006, 11/01/2000 pp. 13-14.
94. ALAN MCHUGHEN, PANDORA'S PICNIC BASKET-THE POTENTIAL AND HAZARDS 01'
GENETICALLY MODIFIED FOODS 97 (2000). This calculation is based on the annual consump-
tion of canola oil in the UK, the amount of protein present in the oil, and the percentage of
modified protein attributable to bioengineering. Id. Providing an example with which to com-
pare these exposures, the author states, "The amount of arsenic that most people ordinarily
ingest in food or water ... is about 18.25 milligrams per year, [which] is not considered to be
of health concern." Id.
95. The method currently employed for detecting minute amounts of modified genetic
material is the polymerase chain reaction, or PCR. For a concise explanation of the basic
principles, see Lori A. Kolmodin & J. Fenton Williams, PCR-Basic Principles and Routine
Practice in PCR Cloning Protocols, 67 METHODS IN MOLECULAR BIOLOGY 3 (Bruce A.
White, ed. 1997).
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investigation in order to work. 6 Policing whether or not rDNA may be pre-
sent in the food then becomes troublesome, because requiring a copy of the
very rDNA in question for its detection may intrude on a manufacturer's
right to maintain processing and manufacturing details as trade secrets."
The bioengineering process itself has come under attack as an alterna-
tive to attacking the food produced using the technology." The Federal
Food, Drug, and Cosmetic Act does not require disclosure of the method of
manufacture, and the Act considers the method of manufacture immaterial.9
How food is produced may be a factor in determining the safety or nutrition
of the finished food, but the key factors in determining food safety should be
the characteristics of the food itself, rather than the methods used to produce
it.'" Precautionists warn that not everything is known about the potential
consequences of biotechnology and that the very process of genetic manipu-
lation may be unsafe and therefore material.'' Most are staunch supporters
of the precautionary principle, one rendition of which states that "(a]ctivities
which are likely to pose a significant risk to nature shall be preceded by an
exhaustive examination; their proponents shall demonstrate that expected
benefits outweigh potential damage to nature, and where potential adverse
effects are not fully understood, the activities should not proceed.' The po-
tential costs and benefits of bioengineered foods have recently been ad-
dressed, 3 and although some consumer concerns may be understandable,"
96. Id. at 3. See also R. D. Pridmore et al., Genoinics, Molecular Genetics and rte Food
Industry, 78 J. BIOTECHNOL. 251 (2000); B. E. Erickson. Detecting Genetically Modified
Products in Food, 72 ANAL. CHEM. 454A (2000); M. Vaitilingom et al., Real-Tine Quantita-
tive PCR Detection of Genetically Modified Maximizer Maize and Roundup Ready Soybean in
Some Representative Foods, 47 J. AGRIC. FOOD CHEM. 5261 (1999); and S. Vollenhofer et al.,
Genetically Modified Organisms in Food-Screening and Specific Detection by Pol yzerase
Chain Reaction, 47 J. AGRIC. FoOD CHEM. 5038 (1999).
97. Trade secret and confidential commercial information, as well as manufacturing
methods or processes, including quality control procedures, arc considered information pro-
tected from disclosure by the Food, Drug, and Cosmetic Act regulations 21 C F.R. § 312.130
and 21 C.F.R. § 314.430.
98. See Julie Teel, Regulating Genetically Modified Products and Processes: An Over-
view of Approaches, 8 N.Y.U. ENVTL. L.J. 649, 655-58 (2000) and J. Howard Beales 111,
Modification and Consumer Information: Modern Biotechnology and the Regulation of In-
formation, 55 FOOD & DRUG L.J. 105, 108-11 (2001).
99. See Karen A. Goldman, Labeling of Genetically Modified Foods: Legal and Scien-
tific Issues, 12 GEo. L'T'L ENvTL. L. REV. 717, 723 (2000) (citing United States v. Ninety-
five Barrels (More or Less) Alleged Apple Cider Vinegar. 265 U.S. 438. 445 (1924)).
100. See Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg.
22984, 22984-85 (May 29, 1992).
101. See Teel, supra note 96, at 655-58.
102. World Charter for Nature, Oct. 28, 1982. para. 11 (b). 22 I.L.M. 455. 458.
103. Jeffrey K. Francer, Frankenstein Foods or Flavor Savers?: Regulating Biotechnol-
ogy in the United States and European Union, 7 VA. J. SOC. POL'Y & L. 257. 263-65 (2000).
104. See A. Bryan Endres. "GMO:" Genetically Modified Organism or Gigantic Mone-
tary Obligation? The Liability Schenes for GMO Damage in the United States and the Euro-
pean Union, 22 LoY. L.A. L,"r'L & ComP. L. REV. 453, 456 (2000) (suggesting that at least in
Europe, many consumers fear the potential future problems of bioengineered foods because
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most of the stated concerns have been regarded as misdirected from a scien-
tific perspective.' °5
Regardless of one's perspective, the precautionary principle played a
part in the development of the Cartagena Protocol on Biosafety, which will
allow countries to regulate bioengineered food, either by labeling require-
ments or by precluding access to the nation's consumer market."° The Cart-
agena Protocol's rendition of the precautionary principle stated that "lack of
scientific certainty due to insufficient relevant scientific information and
knowledge... shall not prevent [a member nation] from making a decision"
regarding the importation of bioengineered foods." This smacks of a Lud-
dite approach to technology, demanding absolutes when none are avail-
able.'
When confronted with uncertainties, the scientific method suggests that
testing be repeated and confirmed and then repeated and confirmed inde-
pendently."° It is only then that a result is accepted as reproducible, although
not necessarily as true. No scientific evidence exists which suggests that
there is any basis for concern over the safety of bioengineered food as a
class."' Existing regulations address areas of concern such as the introduc-
tion of potential food allergens, toxic substances, or breakdown products."'
Introduction of new products or new technologies all have some inherent
risks, and it is not the total elimination of the risk, but a careful assessment
of the risk that is required. An alternate line of thought states that there is no
risk/benefit analysis for food."2 However, if the risk is manageable and pre-
they relate these products to "recent food scares involving Mad Cow Disease, bacterially con-
taminated meat, and dioxin in poultry, pork, and beef products... [where the] affected coun-
try's government either suppressed inconvenient scientif ic data or directly lied about the
food's safety.").
105. See John Stephen Fredland, Unlabel Their Frankenstein Foods!: Evaluating a U.S.
Challenge to the European Commission's Labeling Requirements for Food Products Contain-
ing Genetically Modified Organisms, 33 VAND. J. TRANSNAT'L L. 183, 187-90 (2000).
106. Convention on Biological Diversity, Cartagena Protocol on Biosafety. at
http://www.biodiv.org/biosafety/iccp.asp (last visited Apr. 5, 2001).
107. Id. at art. 10, § 6.
108. See ERIC D. HIRscn, DICTIONARY OF CULTURAL LITERACY 225 (2d ed. 1993). In the
early 1800s, a Luddite protested the use of laborsaving machinery by destroying it. In modern
usage, the term refers to any opponent of technological change. Id.
109. The scientific method is generally defined as an orderly technique of investigation.
"The method consists of the following steps: 1. Careful observation of nature. 2. Deduction of
natural laws. 3. Formation of a hypothesis [to explain the observations]. 4. Experimental or
observational testing of the validity of the predictions thus made." Id. at 487.
110. Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or
Have Not Been Developed Using Bioengineering; Availability, 66 Fed. Reg. 4839 (Jan. 18.
2001).
111. Statement of Policy: Foods Derived From New Plant Varieties, 57 Fed. Reg. 22984,
22986-22988 (May 29, 1992).
112. Elizabeth A Yetley, Energy for a new millennium-Regulatory perspectives.
NUTRITION REVIEWS, January 1, 2001 ("For food, safety means reasonable certainty of no
harm: there is no risk-benefit assessment for food.").
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sents little danger of harm, then the risk is acceptable. Although statistics are
often useful for comparative risk assessment, taken out of context the same
assessment could be interpreted to suggest that the amount of risk is
unacceptable.'
B. Consumer Interest vs. Consumer Interest Groups
Regardless of the magnitude of the potential risks, some consumers de-
mand the right to know what is in their food, or how it got there.'" An inter-
esting statistical analysis would be to determine how much of the labeling
demand comes from consumers, versus how much of the demand could be
attributed to consumer interest groups."' Public interest groups are becoming
more vocal and more litigious. The Center for Science in the Public Interest
(CSPI)"6 is one such group that has indirectly taken on the FDA on a number
of labeling issues. Some examples of these include attacks made on the offi-
cial serving size standards established by the FDA,"7 the fat content of meals
served at Chinese, Mexican, and Italian restaurants,"' and Olestra, the fat
substitute created by Proctor and Gamble." 9 In addition to an increased par-
ticipation by consumer interest groups, there appears to be a steady increase
in "the use of junk science to promote certain political agendas while ignor-
113. See McHUGEN, supra note 94, at 129-35. This author provides a comprehensive
overview of risk assessment relative to genetically modified organisms in food. An interesting
corollary he interjects is that while the opponents of bioengineered food demand assurances
that bioengineered food is risk free, similar demands are not made for conventional versions
of the same product, even though the risks may be higher. "Failure to consider all of the rele-
vant comparisons [between the two products] leads to erroneous conclusions." Id.
114. For example, in Alliance for Bio-lntegrity v. Shalala. 116 F. Supp. 2d 166 (D.D.C.
2000), the plaintiffs "expressed fears that bioengineered food would contain unexpected tox-
ins or allergens, while others believed that their religion prohibited consumption of foods pro-
duced through rDNA technology." 116 F. Supp. 2d at 175.
115. For example, Greenpeace began launching their campaign against bioengineered
food in the U.S. in 1999. See Seeds of Doubt: Some Ingredients are Genetically Modified, De-
spite Labels, supra note 2, at *4. Meanwhile, the Genetically Engineered Food Alert, a coali-
tion which includes members of the Center for Food Safety. Friends of the Earth, and the Pub-
lic Interest Research Groups leads in the demand for mandatory labeling of all biocngineered
food. See Steve Lash, Industry Gives Qualified Support for Voluntary Labeling (Food Indus-
try Follows FDA's Standards for Genetically Modified Foods), 43 FOOD CHEMICAL NEvs, 1
(Apr. 2, 2001), available at 2001 WL 12772928.
116. Michael Jacobson, the leader of CSPI, has been described as a non-compromising
zealot or idealist likened to the Ayatollah Khomeini. BINNrr & DtLOREN'zo. supra note 1. at
6 (quoting Jeff Nedelman, Grocery Manufacturers of America. from Stephen Glass, Ilazard-
ous to Your Mental Health, NEw REPuBuC, Dec. 30. 1996 p. 18). while Bernadine Healy,
former director of the National Institutes of Health, said that the Center for Science in the
Public Interest is "really a misnomer. It's not always science, and these mini-scares are not in
the public interest." Id
117. JAMiEs T. BENNTT & THo~MAs J. DiLORIDNZO. Tim FOOD & DRLNK POUCE-
AMERICA'S NANNIES, BUSYBODIES & PEry TYRANrs 10 (1999).
118. Id at 22-24.
119. ld. at93-100.
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ing genuine science that may be critical of that agenda.""'2 The combination
of these forces may result in a less-informed consumer. "It is one thing to
simply provide citizens with information about healthy lifestyles; it is quite
another thing to provide citizens with dubious or false information that pro-
motes a prohibitionist agenda." 2'
C. Consumer Right to Know
The FDA is the administrative agency that makes sure that such dubious
or false information never makes it on to the food label. Still, a consumer
may demand that a "right to know" exists.
A "right to know" could be invoked to justify labeling about any detail
of the production process, from use of chemical fertilizers, to the wage rate
and national origin of the workers who planted and harvested the crop, to the
labor practices of the manufacturer, to the soil conservation practices of the
farmer. It is impossible to list all the things that might matter to everyone...
the "right to know" is limitless.'22
However, consumers may not want to know everything about the food
they purchase.' The FDA regulates the manufacture of food and prohibits
the sale of any adulterated product."' A manufactured food product is con-
sidered adulterated if it contains excessive amounts of poisons, pesticide
residues, additives, filth, or decomposed matter.'25 The FDA has established
threshold limits for acceptable levels of these contaminants. Trace amounts
of these materials are allowed because of technical or economic prohibitions
on removing them.'26 Preservatives, flavors, and colorants in very small con-
centrations are safe for food use, but potentially dangerous at high concen-
trations.'27 The presence of even trace amounts of rat hair or insect fragments
may be material to some consumers. But in terms of food quality or public
health, as long as the levels are below those set by the FDA, the manufactur-
ing process is acceptable and the resulting food is not adulterated. 2 Addi-
120. Id. at 15.
121. Id.
122. See J. Howard Beales III, Modification and Consumer Information: Modern Bio-
technology and the Regulation of Information, 55 FOOD & DRUG L.J. 105, 109 (200 1).
123. NEIL POSTMAN, TECHNOPOLY 74 (1992) (suggesting that too much information is a
bad thing, because providing an overwhelming amount of information makes society uncer-
tain and unable to ascertain the truth).
124. 21 U.S.C. § 301 (2001).
125. 21 U.S.C. § 342 (2001).
126. See generally Michael Merrill, Regulating Carcinogens in Food: A Legislator's
Guide to the Food Safety Provisions of the Federal Food, Drug, and Cosmetic Act. 77 Mic'i.
L. REv. 171 (1978).
127. Id.
128. See 21 U.S.C. § 342 (2001); see also Defect Action Levels for the Adulteration of
Wheat Flour and Macaroni Products by Insects, 53 Fed. Reg. 1520 (January 20, 1988) (where
the FDA has established the "defect action level" of insect fragments present in flour to be 75
fragments per 50 grams of flour, while that for macaroni and noodle products is 225 insect
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tionally, there are no labeling requirements for the "amount or type of fungal
spores or bacterial toxins"'" in foods. As long as these components fall
within the FDA guidelines, the foods are safe and no labeling is required.
Further, some foods may contain natural substances that are toxic to humans;
nevertheless, under the FDA guidelines, the food is not adulterated "if the
quantity of such substance in the food does not ordinarily render it injurious
to health."'" It is of interest to note that many of these natural toxins are
prevalent in organic foods."'
IV. FOOD ADDITIVES
A. Definition and Regulation
The FDA has established similar guidelines for food additives." Food
additives are defined in Section 201 of the Federal Food, Drug, and Cos-
metic Act as
any substance the intended use of which results or may reasonably be ex-
pected to result, directly or indirectly, in its becoming a component or oth-
erwise affecting the characteristics of any food (including any substance
intended for use in production, manufacturing, packing, grocessing, pre-
paring, treating, packaging, transporting, or holding food).
Food additives include processing enzymes that may or may not be pre-
sent in the final food, food colors and flavors, preservatives, sweetening
agents, and thickening agents."M Many food additives are substances that are
"generally recognized as safe" (GRAS) based on appropriate scientific
evaluation." 5 The GRAS exemption will continue to apply as long as a
fragments per 225 grams of macaroni).
129. See McHUGHEN, supra note 94, at 211.
130. 21 U.S.C. § 342(a)(1). A common example would be aflatoxin. produced by the
fungus Aspergillusflavus, that attacks diverse food crops including peanuts, corn, and cotton-
seed (see Charles W. Henderson, Researchers Work to Combat Dangerous Fungal Com-
pounds, CANcER WEEKLY, September 26, 2000, available at 2000 WL 19896262). Another
example is the mycotoxin, patulin, produced by a mold that grows on bruised applcs; it has
been found in 20% of all apple juice samples tested. See Hazard Analysis and Critical Control
Point (HAACP); Procedures for the Safe and Sanitary Processing and Importation of Juice, 66
Fed. Reg. 6138, 6142 (January 19, 2001).
131. See Dennis T. Avery, The Hidden Dangers in Organic Food (1998), available at
http://www.americanoutlook.org/articles-fa98/avery.htm (last visited November 21, 2001).
132. See 21 U.S.C. § 321(s)(4) (2000).
133. Id. at § 321(s).
134. See Evaluation of Certain Food Additives. Fifty-first Report of the Joint FAO/AHO
Expert Committee on Food Additives, World Health Organ. Tech. Rep. Ser. 891. 1 (2000).
135. 21 U.S.C. § 321(s) (2000). A substance can be granted GRAS status if trained and
experienced scientific experts agree that adequate safety has been shown through scientific
procedures. 21 C.F.R. § 170.30(b) (2000). However, substances that were used in foods prior
to Jan. 1, 1958, may be granted GRAS status based on a substantial history of human con-
sumption in the United States, under 21 C.F.R. § 170.30(c).
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manufacturer uses that substance in the quantity and manner generally re-
garded as safe.'36 Any new food additive is presumed unsafe unless a quali-
fied person either establishes that it is GRAS'37 or establishes the safety of
the substance in food under the conditions for its intended use.'38 A similar
approval process must be followed when a manufacturer wishes to use an
approved food additive in a new way.'39 The procedures used to obtain FDA
approval of a new compound as a food additive are rigorous, and petitions
for approval must contain:
information on the chemical identity and composition of the food additive;
the conditions of proposed use of the additive, including directions for
use; data concerning the effects of the additive, including quantities re-
quired to produce such effects; methods for detecting the presence of the
additive and any metabolites; and disclosure of reports of investigations
concerning the safety for use.?4
Once the substance is approved, the FDA will issue a regulation "pre-
scribing... the conditions under which such additive may be safely used."''
There is a significant difference between food additives that are GRAS and
those that have been approved through FDA petition. The only limitation on
the use of GRAS food additives is that they be used in accordance with good
manufacturing practices (GMP).' 2 Food additives approved by petition to
the FDA may be subject to regulations imposing conditions on their use in-
cluding "the category of food, the technical effect or functional use, and the
level of use."'4 3
B. Bioengineered Foods and Food Additives-Guidance Required
As mentioned in Section IID above, the FDA has afforded bioengi-
neered food ingredients GRAS status. Under this designation, their use in
foods would normally be regulated under the GMP standard.'" And although
the 1992 Guidance dealt only with food derived from genetically modified
plants, the 2001 Labeling Guidance covers foods that are bioengineered or
contain bioengineered ingredients.' " The purpose of the guidance is "to as-
136. 21 C.F.R. § 188.22 (2000) (the GRAS exemption will apply if the additive is of
good commercial food grade and used in accordance with good manufacturing practices).
137. 21 U.S.C. § 348(a) (2000).
138. Id. at § 348(b).
139. Id.
140. See 21 U.S.C. § 348(b)(2).
141. See 21 U.S.C. § 348(c)(1)(A).
142. 21 C.F.R. § 182.1(b) (2000).
143. 21 C.F.R. § 184.1(b)(1) (2000).
144. 21 C.F.R. § 182.1(b) (2000).
145. Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or
Have Not Been Developed Using Bioengineering; Availability, 66 Fed. Reg. 4839 (Jan. 18.
2001).
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sist manufacturers who wish to label their foods voluntarily as being made
with or without the use of bioengineered ingredients."" 6 The proactive ap-
proach of the FDA should be applauded. Specifically, the agency is request-
ing comments on the use of the terms "GMO free," "biotech free," and "no
genetically engineered materials" and whether such statements could be
made without being false or misleading.'' The agency demonstrated the dif-
ficulty in using this terminology on labels since such wording implies a
"zero content" claim, which it concluded would be "very hard to substanti-
ate."" In terms of food additives, the difficulty comes in determining where
to draw the line demarcating bioengineered food from traditional food.
Although a reasonable consumer may suspect that tortillas could contain
bioengineered corn or that tofu may contain bioengineered soybeans, it may
not be as obvious to most consumers that even chocolate cake might be sub-
ject to a bioengineered food label. The ingredient list for a commercial
chocolate cake mix'" included partially hydrogenated soybean oil, ribofla-
vin, artificial flavors, and xanthan gum. The soybean oil would be an obvi-
ous potential product of bioengineering. What is not as obvious is that the
riboflavin may have been produced using bioengineered microorganisms, or
that corn syrup or protein derived from bioengineered plants was used in the
fermentation media for the bacteria used to manufacture the artificial fla-
vors 1 50 or the xanthan gum. The label itself declares that the dry cake mix
contains less than two percent artificial flavors or xanthan gum."' If the
"zero content" standard were adopted, then any use of bioengineered mate-
rial anywhere in the manufacturing process would potentially make the final
food subject to labeling. Such a standard has been adopted in Europe'" and
results in an interesting phenomenon. Any intentional introduction of a bio-
engineered material into a food results in automatic mandatory labeling.'" If,
however, the amount of material is less than the de nzininis threshold (set at
one percent) and the material was introduced adventitiously, then no labeling
is required." Tracing the origin of all raw materials has introduced a new
146. Id. at 4840.
147. Id.
148. Id.
149. Duncan Hines' Moist Deluxe" Devil's Food Cake Mix.
150. See U. Krings & R. G. Berger, Biotechnological Production of Flavors and Fra-
grances, 49 APPL MICROBIOL. BIOTECHNOL 1 (1998).
151. Xanthan gum is regulated under 21 C.F.R. § 172.695. According to the Product
Data Sheet for CP Kelco's KELTROL xanthan gum, the typical use level is 0.05-0.5%.
Available online at http://www.cpkelco.com.
152. Council Regulation (EC) No. 1139198 concerning the compulsory indication on the
labeling of certain foodstuffs produced from genetically modified organisms of particulars
other than those provided for in Directive 79/112/EEC, Official Journal L 244. 03/09/1998 p.
20 (1998) (which states that the intentional introduction of bioengineered material into a food
results in the compulsory labeling of that food as being produced from genetically modified
organisms).
153. Id.
154. Commission Regulation (EC) No. 49/2000 of 10 January 2000 amending Council
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phraseology in the ingredient-manufacturing vernacular: identity preserva-
tion."'55 In order to ensure that a zero bioengineering material claim can be
made in the EU, a few U.S. companies have already started to track the ori-
gin of raw ingredients.'56 The FDA anticipated in its 2001 Draft Guidance
that absent a validated testing protocol to ensure that a product does not con-
tain bioengineered ingredients, such a document handling system would
need to be established.'57 This could impose a bureaucratic and logistical
nightmare on many manufacturers. The FDA estimates that a one-time bur-
den for voluntarily labeling bioengineered food would be close to $2 mil-
lion. "'58 But the FDA does not address how far back in the chain one needs to
venture in order to assure that no genetic modifications ever occurred in any
ingredient which may eventually end up in that chocolate cake.
An alternative to the "zero content" standard would be a de minimis
standard, similar to that adopted by the EU for adventitious contamination."'
The FDA has not promulgated any de minimis levels below which an ingre-
dient could be exempt from labeling, and this author argues that many food
additives (most of which are used at levels less than the EU de minimis stan-
dard of one percent) should be exempt from labeling. It has yet to be ad-
dressed whether aggregation of all the ingredients would be appropriate to
determine the de minimis content of the food. To ensure uniformity, it is rec-
ommended that the FDA address this issue rather than allow market discre-
tion to establish independent criteria. Recommendations by the National
Food Producers Association (NFPA) are a good start; these include estab-
lishing a "quantitative threshold for what is GMO-free, [requiring] compa-
Regulation (EC) No. 1139/98 concerning the compulsory indication on the labeling of certain
foodstuffs produced from genetically modified organisms of particulars other than those pro-
vided for in Directive 79/1 12/EEC, Document 300R0049, Official Journal L 006, 11/01/2000
pp. 13-14 (introducing the de minimis threshold of one percent for adventitiously introduced
genetically modified material into food).
155. Compare John Stephen Fredland, Unlabel Their Frankenstein Foods!: Evaluating a
U.S. Challenge to the European Commission's Labeling Requirements for Food Products
Containing Genetically Modified Organisms, 33 VAND. J. TRANSNAT'L L. 183, 192 (2000)
with Lara Beth Winn, Special Labeling Requirements for Genetically Engineered Food: low
Sound are the Analytical Frameworks Used by FDA and Food Producers. 54 FOOD & DRI(;
L.J. 667, 688 (1999).
156. Pillsbury, for example. See Winn, supra note 155, at 685 n. 106.
157. See Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods
Have or Have Not Been Developed Using Bioengineering; Availability, 66 Fed. Reg. 4839
(Jan. 18, 2001) (suggesting that manufacturers that wish to label a food using a free claim
would need to document the source of the food, "demonstrat[ing] handling practices and
procedures about how the food was processed ... [including] affidavits from farmers.
processors, and others in the food production and distribution chain."
158. See id. at 4841.
159. See Commission Regulation (EC) No. 49/2000 of 10 January 2000 amending Coun-
cil Regulation (EC) No. 1139/98 concerning the compulsory indication on the labeling of cer-
tain foodstuffs produced from genetically modified organisms of particulars other than those
provided for in Directive 79/112/EEC, Document 300R0049, Official Journal 1, 006,
110/02000 pp. 13-14.
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nies to keep substantiating information to back their claims, and [adding] ac-
companying statements to put the claims in context.'"
V. POTENTIAL FOR MISCHIEF AND CONFUSION
Although the 2001 Draft Guidance on labeling is intended for manufac-
turers who voluntarily wish to label their foods regarding the presence or ab-
sence of bioengineered products, it does introduce the potential for mischief
and confusion throughout the food industry. The number of products poten-
tially affected is high. "In the U.S., an estimated 60 percent of processed
foods-from breakfast cereals to soft drinks--contain a [bioengineered] in-
gredient, especially soy, corn, or canola; some fresh vegetables are geneti-
cally altered as well." '61 The introduction of labeling changes can have posi-
tive as well as negative effects." An example of an effective labeling change
imposed by the FDA was the 1994 introduction of regulations for uniform
nutritional labeling." Within a year, "56 percent of consumers used the la-
bels often to check nutrients and compare brands."' However, only four
years later, "sophisticated shoppers, irritated with what many considered
misleading information," checked the labels less frequently."
The consumer is bombarded with contradictory messages of what is
good for you and what is bad for you." These contradictory messages breed
160. NFPA Calls on FDA to Define "Biotech Free" in Product Testing Standards. Food
Labeling News. Apr. 26, 2000, available at 2000 WL 11948741. * 1.
161. Karen Hopkin, The Risks on the Table, 284 ScmErlIc AMERICAN 60 (2001).
162- See Hollie Weaver Beason, Nutrition: Learn otow to Interpret Labels on Food
Products, GANEt NEws SERvic, May 9, 2000, available at 2000 WL 4399166. As an ex-
ample, the labeling of milk is undergoing a labeling change, in an effort to make the descrip-
tive terms used to describe the fat content more comparable to other reduced fat foods. Milk
labeled "2 percent" will now be labeled "reduced fat"; "1 percent" milk will be labeled "low
fat" or "light"; and "0 percent" milk can be labeled "fat free," "skim." or "nonfat." It is this
author's opinion that the numerical designation of butterfat content was more informative and
easier to understand.
163. See Guy Gugliotta, Nutrition Labels Both a Success and Failure, PORTLAND
OREGONIAN, May 30, 2000, available at 2000 WL 5407122 (opining that the regulations
"were designed to set government standards for the labeling of processed foods. [and] im-
pose[d] accuracy and uniformity on conflicting and often misleading information provided by
food companies").
164. ld
165. Id
166. For example, eggs were condemned as causing high cholesterol which resulted in an
almost 50 percent reduction in per capita consumption, although few studies showed any cor-
relation to high cholesterol, while nutritionists viewed eggs as high in protein and iron yet low
in fat and calories. BEmmmr & DtLOR2.zo, supra note 1, at 21. Coffee was maligned as caus-
ing heart disease and pancreatic cancer, but five years after the study supposedly supporting
the claims, the authors could not verify the causal link. Id. at 27. Butter was taboo because of
its high cholesterol content, and many Americans switched to margarine, only to be told later
that the trans fatty acids in margarine may cause heart disease. Id. at 28. Finally, a "startling"
good surprise from the National Center for Health Statistics in 1996 when it:
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mistrust. In addition, too much information might result in "information
overload" where an overwhelming amount of information causes consumers
to completely ignore most or all of the information presented.'6" What ap-
pears on a label may also influence the confidence of the consumer. An ex-
ample would be the warning label on products containing OlestraT fat sub-
stitute. Olestra was "the first no-fat, no-calorie, fat substitute."'' 8 The
problem with Olestra is that because of the chemistry of the molecule, it is
not absorbed by the body and passes through the intestinal tract intact.'69
Proctor & Gamble supplied the FDA with more than 150,000 pages of data,
making it "the most thoroughly tested new food ingredient ever considered
by the FDA."'70 Because Olestra was not absorbed and it could dissolve fat-
soluble vitamins, Proctor & Gamble agreed to add the fat-soluble vitamins
directly to Olestra.'7' However,
[t]here was one other FDA string attached.... Products made from Oles-
tra must bear this label: 'The product contains Olestra. Olestra may cause
abdominal cramping and loose stools. Olestra inhibits absorption of some
vitamins and other nutrients. Vitamins A, D, E, and K have been added.'
This warning label was required even though Olestra 'is less of a problem
than baked beans, dietary fiber, or prunes.
The Center for Science in the Public Interest (CSPI) was determined to
keep Olestra off the market and generated national publicity campaign to
stop "greasy feces" from overtaking America.'73 And their campaign seems
to have been successful, as evidenced by the lack of Max chips (the first
product launched containing Olestra) on grocery shelves in San Diego.
hypothesized that the reason for the falling rate of heart disease is not only exercise
but the artificial flavorings used in junk food. .... The heart-friendly element in
many artificial flavors appears to be salicylates, which are related to aspirin, which
helps to prevent blood clots .... [Tihose flavors ... are strawberry, grape, butter,
vanilla, cinnamon, mint, caramel, and walnut.
Id. at 28-29.
167. Jacob Jacoby et al., Corrective Advertising and Affirmative Disclosure Statements:
Their Potential for Confusing and Misleading the Consumer, J. MARKETING, Winter 1982, at
61. For a review of overload theory, see Jason R. Penzer, Grading the Report Card: Lessons
from Cognitive Psychology, Marketing, and the Law of Information Disclosure for Quality
Assessment in Health Care Reform, 12 YALE J. ON REG. 207, 238-39 (1995).
168. See BENNETIT& DILORENZO, supra note I, at 93.
169. Id.
170. Id. at 95 (citing Keith C. Triebwasser, Speaker Notes Used at FAC [Food Advisory
Committee of the FDA] Meeting, Nov. 1995, p. 12).
171. Id. See also Food Additives for Direct Addition to Food for Hluman Consumption;
Olestra, 61 Fed. Reg. 3118-01 (Jan. 30, 1996).
172. See BENNETT & DILORENZO, supra note 1, at 97 (quoting Michael Parize. director
of the Food Research Institute at the University of Wisconsin-Madison, from CSPI Throws
Consumer Choice Down the Toilet, Says Consumer Alert, press release (Washington, DC:
Consumer Alert, 1 July 1996)).
173. See BENNETT& DILoRENZO, supra note 1, at 98.
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Charles Grossman stated in the Journal of the American Medical Association
that "it is both inappropriate and wrong for special-interest groups to play on
the health and safety fears of the public to further their own ends."'7'
VI. CONCLUSION
Regardless of one's stance on the issue, the GMO labeling issue is now
"the genie escaped from the bottle [and] is not easily cabined." ''" It is now up
to the FDA to ensure that these labels are used for the benefit and not detri-
ment of the American consumer. The FDA's proactive approach to provide
guidance to the food industry on voluntary labeling of bioengineered food is
laudable. In seeking feedback from the industry, a win-win situation for all
involved can be accomplished with little uncertainty as to potential mis-
branding of products."6 In order to attain this goal, the issue of bioengi-
neered food ingredients needs to be addressed. Additional data need to be
collected to ascertain the effects, on both manufacturers and consumers, of
the voluntary labeling of foods as "GMO" in which the only bioengineered
ingredient is a food additive that constitutes only a small fraction of the total
composition of the food. In addition, it must be determined whether con-
sumers and manufacturers who advocate the "non-GMO" label desire to
have products completely devoid of bioengineered products.
The prevalence of the "non-GMO" label on certain grocery shelves sug-
gests that these labels will not be easily regulated away, regardless of the
scientific data that may be presented. While the debate continues on foods
that are entirely or predominately composed of a bioengineered food crop,
little time has been devoted to the issue of food additives that either utilize
bioengineered crops during manufacture or utilize biotechnology techniques
for production of the food ingredient. Two alternative strategies are pre-
sented for consideration for the regulation of labeling food where the only
potential bioengineered component is a food additive-prohibition of "non-
GMO" labels or regulation under the National Organics Act. Both of these
strategies have their own advantages and disadvantages, as discussed below.
174. Id. at 110 (citing Charles J. Grossman, Genetic Engineering and the Use of Bovine
Somatotropin, 22 JAMA, 1003 (1990) (speaking about a similar scare raised concerning the
use of recombinant bovine somatotropin (bST) and the potential hazardous effects to people
drinking milk from cows treated with recombinant bST)).
175. See Welch v. Cadre Capital, 735 F. Supp. 467, 478 (U.S. Dist.. 1990); available at
1990 U.S. Dist. LEXIS 4357, *7.
176. See Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods
Have or Have Not Been Developed Using Bioengineering; Availability. 66 Fed. Reg. 4839,
4840 (2001) (requesting comments on the nomenclature to be used on the labeling, and in-
formation regarding the collection of information that would constitute identity preservation).
2001]
27
Miskiel: Voluntary Labeling of Bioengineered Food: Cognitive Dissonance in
Published by CWSL Scholarly Commons, 2001
CALIFORNIA WESTERN LAW REVIEW
A. Prohibition of the "non-GMO " label
When the food product is predominately free of any bioengineered food
component, it is recommended that all "non-GMO" labeling be prohibited as
unnecessary. Current regulations governing food ingredients, including those
manufactured using biotechnology, address any potential safety and health
issues.' These food ingredients are generally used at very low levels in
food, and, even if added together, would generally constitute less than ten
percent of a final food product.'78
The issue to be addressed is how to define "predominately free" of bio-
engineered food components in a final food product. The ten percent figure
could be considered arbitrary. Is it too high? Would five percent or less be
more appropriate? As discussed in this article, the bulk of the scientific evi-
dence suggests that bioengineered food per se is no different than traditional
foods, and that labeling them is unnecessary. But due to consumer demand
and marketing pressure, although this may be the best logical alternative, it
may no longer be a viable one. Consumer perception and belief may not be
assuaged by scientific evidence. Some consumers believe that "organic"
foods are safer than other foods. But the question is
whether those beliefs are accurate. The record overwhelmingly demon-
strates, through the testimony of soil scientists, nutritionists, fertilizer ex-
perts, pesticide experts, and others, that there is absolutely no difference
between "organic" foods and "non-organic" foods in terms of either nutri-
ent content or safety. Indeed, much of the resistance to the use of the term
stems from the fact that there is no difference between "organic" and
"non-organic" food, thus leading to the conclusion that the distinction
drawn is spurious from a scientific standpoint.'
79
If one would substitute "bioengineered" for "organic" in the above
quote, the conclusion would be the same. We are therefore faced with the re-
ality that some standard will need to be established for determining how
much of a bioengineered food ingredient should make a final food product
ineligible for a non-GMO label. It is recommended that the FDA establish a
de minimis standard for food ingredients, below which GMO-labeling would
be prohibited.
177. 21 U.S.C. § 348(a) and (b) (2000).
178. For instance, consider our cake mix from Section IV above. The ingredients are
listed in descending order by weight. The ingredients constituting the bulk of the cake mix are
sugar and flour. In chocolate cakes, processed cocoa is the next predominant ingredient. Par-
tially hydrogenated oils are next, followed by leavening agents, mono- and diglycerides, salt.
xanthan gum, flavors, and colors. Even assuming that the xanthan gum was used at 0.5%, and
that hydrogenated soybean oil was used at 5%, adding in the flavors and colors would not
reach the 10% level.
179. See Nat'l Nutritional Foods Ass'n v. Whelan, 492 F. Supp. 374, 381 (U.S. Dist.,
1980) (quoted from Staff Report and Recommendations, Federal Trade Commission, Septem-
ber 25, 1978, p. 238).
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1. De Minimis Standard
If consumers and manufacturers who advocate non-GMO labeling are
willing to accept bioengineered food additives in the final product at some
small levels, then the FDA must promulgate what threshold would be ac-
ceptable, and by what methods that level can be ascertained. This threshold
would then be established as the de mininis standard, and food containing
less than the de minimis level of a bioengineered food ingredient would not
require a "non-GMO" label.
I propose that the EU de mininis standard of one-percent or less of a
food additive should be adopted under this standard. Lynne Jensen, chairper-
son of the Board of the National Corn Growers Association, has stated that
existing limitations on how U.S. commodity grain is processed will make a
zero tolerance of bioengineered products almost impossible, and suggests
that the FDA will "have to search for a number that's both palatable and do-
able."'" A problem that would need to be addressed is the effect on the de
minimis level when more than one food additive is present in a food product.
I recommend that an arithmetic aggregate of each individual ingredient's
contribution to the final product would be an appropriate approach in multi-
ingredient products. But first, it must be determined how a "bioengineered
product" is defined in a de ininimis scenario, since this may have an effect
on whether to subject the final product to the voluntary label.
As an illustrative example, suppose that the manufacturer of our choco-
late cake mix from Section IV is struggling with the labeling issue. They
have replaced the soybean oil with sunflower oil that is not bioengineered.
The artificial flavors and the riboflavin that they use are also produced using
traditional technology. The only question remaining is whether the cake mix
could be labeled GMO free if the xanthan gum (suppose that it is used at
0.4% based on dry weight of the mix) was made using bioengineered soy
protein during fermentation. Since the xanthan gum itself was made using
non-genetically engineered bacteria, would the inquiry stop there? If the re-
sidual amount of protein in the xanthan gum were five percent, would the re-
sulting 0.02 gram protein per 100 grams cake mix potentially from bioengi-
neered soy make the cake mix bioengineered? But of the total protein
content, if we assume that only one picogram [0.000 000 000 001 gram] is
DNA,"' then 100 grams of cake mix contains five billionths of one percent
DNA; furthermore, only a portion of that DNA has been modified. If this
were insect fragments, the courts would consider this a "trifle, not a matter
of concern to the law."'1' "
180. See Kathleen Hart, USDA, FDA grappling wiih identity preservation issues, 43
Food Chemical News *3, July 2, 2001, available at 42001 WL 12773479.
181. See McHUGHEN, supra note 94, at 96. If linseed typically contains about one half a
picogram of the protein as DNA, then one picogram is a reasonable estimate for soybean. Id.
182. U.S. v. Capital City Foods, Inc., 345 F. Supp. 277, 279 (1972).
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In addition, the FDA would need to promulgate rules addressing the is-
sue of liability. If testing done in good faith and using state of the art tech-
nology fails to accurately detect a bioengineered food ingredient, and that
results in the final food product containing more than the de minimis quan-
tity of bioengineered material, should the non-GMO food product be re-
moved from the shelves because of misbranding? Who should assume the
risk of liability? Should such an event even result in misbranding and prod-
uct recall?
Taken together, the many unanswered questions suggest that even
adopting a de minimis standard to establish when a food product could be
subject to voluntary labeling would not be adequate to provide sufficient
guidance to the industry. Since it is unlikely that a complete ban on volun-
tary labeling of bioengineered foods would accomplish the FDA's goals of
protecting the consumer and providing consumer information, another ap-
proach should be considered.
2. Adopting the National Organic Standards for "non-GMO" Labeling
A different yet workable approach would be to eliminate the need for a
separate label identifying bioengineered food. This can be accomplished by
using the organic food label. 83 Allowing a "non-GMO" or "GMO-free" label
only on organic foods would address the most vocal segment of consumers
demanding such labeling, without adversely impacting the entire food indus-
try. Since the regulatory mechanism is already in place for organic foods,
adding the "GMO-free" claim should not introduce confusion into the stream
of commerce with respect to the presence of bioengineered food.
It is this author's opinion that the best approach for addressing the bio-
engineered food-labeling conundrum is to allow only organic foods to be la-
beled as "non-GMO." By definition, an organic food cannot contain geneti-
cally modified material, so "non-GMO" is an accurate label for such foods.
That segment of the industry already has established an identity preservation
system, and has initiated a manufacturing tracking system to ensure that the
products adhere to the government regulations. No additional burdens for re-
cord-keeping or product tracking would be encountered. Companies wishing
to expand into the "non-GMO" food segment would need to meet all the
regulations that exist for organic foods, as outlined in the National Organic
Program."' Implementing this approach would require adopting the zero
content standard.
183. See Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods
Have or Have Not Been Developed Using Bioengineering; Availability. 66 FR 4839. 4842
(2001) ("according to a proposal in the Federal Register of March 13, 2000 [65 FR 135121 a
food labeled as organic would not be permitted to contain biocngineered materials."). See
also, Eric F. Greenberg, Biotech and Organic Rules Related, 38 PACKAGING DIGFST, * 1, Feb
1, 2001, available at 2001 WL 15622399.
184. USDA National Organic Program, 65 Fed. Reg. 80548-01 (2000) (requiring that
certified organic food must not only be free of genetically modified organisms, but must also
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3. Zero Content Standard
In order to comply with the National Organics Program, products will
need to be completely devoid of bioengineered products. The zero content
standard would need to be implemented, and the presence of any bioengi-
neered ingredient would render the final product subject to the voluntary la-
beling scheme. The zero content standard would preclude a "non-GMO" la-
bel on any food shown to contain even trace amounts of recombinant DNA.
Although the zero content standard establishes a bright line approach to this
issue, it brings with it its own consequences. One consequence would be the
requirement for an identity preservation system, which is expected to inject
huge costs into the food industry.' s Even an ideal identity preservation sys-
tem may be unable to meet a zero content standard. But because this mecha-
nism is already in place for the organic food segment, it makes sense that
GMO-labeling should utilize the existing system, instead of creating a new
one. By allowing voluntary labeling only on organic foods, the need for an
independent identity preservation system for the entire food industry can be
avoided.
Another disadvantage that only complete prohibition of the "non-GMO"
label avoids is the requirement that a uniform analysis system be developed.
The detection of the bioengineering modification presents both scientific and
legal burdens. As discussed earlier, the existing PCR technology requires a
primer segment in order to ascertain what modifications have been made. If
a manufacturer needs to provide such a primer sequence in order to develop
and utilize a PCR detection system, trade secret issues would need to be ad-
dressed. Further, once a detection system is established, it will need to be de-
termined whether all manufacturers in a product chain must do their own
testing.
Again, as an illustrative example, let us consider the manufacturer of
our chocolate cake mix from Section IV. The mix is to be labeled "non-
GMO." In order to ensure that the ingredients used during manufacture of
the cake mix contain no bioengineered ingredients, they purchase raw mate-
rials only from manufacturers that maintain an identity preservation system
and certify that their ingredients are "GMO free." Unless they produce only
GMO-free food products in their manufacturing facility, there is the poten-
tial of cross-contamination with even trace amounts of bioengineered prod-
ucts that could show up in the final product. Because even trace amounts of
be cultivated without the use of sewage sludge, synthetic chemical fertilizers, pesticides, her-
bicide, growth hormones, or treated using radiation).
185. See Rick Weiss, Next Food Fight Brewing is Over Listing Genes on Labels. WAsH.
POST, Aug. 15, 1999, at A17 ("expensive separate transportation and processing streams for
engineered and nonengineered foods" will be required to maintain the identity preservation
system); see also, Henry I. Miller, A Rational Approach to Labeling Biotech-Derived Foods,
284 ScIErNcE 1471 (1999) ("both traditional and bioengineered food would have to be segre-
gated throughout all phases of production, including planting, harvesting. processing. and re-
tail distribution").
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bioengineered products under the zero content standard would preclude us-
ing a "non-GMO" label, further testing of the final cake mix would be re-
quired to ensure that it is indeed free of any bioengineered product. But the
cake mix may comprise more than a single "potentially bioenginecred" in-
gredient, and each separate ingredient would require a unique PCR identifi-
cation test. Multi-food product producers, such as Kraft and Nabisco, for ex-
ample, would need to establish facilities dedicated solely to the production
of non-bioengineered food products to eliminate potential cross-
contamination. They would also need personnel to do nothing but run identi-
fication testing.
The testing regime itself will inject additional costs at every step of the
manufacturing chain, resulting in a large cumulative cost that will need to be
captured in the form of higher retail prices. By allowing a "non-GMO" label
only on organic foods, the costs associated with testing can be avoided by all
food manufacturers not wishing to produce foods that could be labeled as
"non-GMO." Because organic food consumers are already willing to pay the
higher prices associated with organic foods, it seems likely that any addi-
tional costs that would result from allowing a "non-GMO" label to be placed
on organic foods would be acceptable to that segment of the food consumer
market.
An additional issue that will need to be addressed is the methods for de-
tecting bioengineered products in food. The government will need to deter-
mine how detection testing will be conducted, and who should bear the costs
of developing such testing. By limiting the use of voluntary labeling of bio-
engineered foods to those that comply with the National Organic Program,
the playing field has been narrowed, and this issue may be more manage-
able. In addition, the legal issues surrounding divulging trade secrets of food
product manufacture would potentially be minimized because those manu-
facturers not wishing to divulge such information may avoid doing so by not
participating in the organic food market.
In conclusion, bioengineered food and bioengineered food ingredients
are not materially different from those produced by traditional methods.
Since voluntary labeling would seem to cause more confusion than provide
relevant information to the consumer, I recommend that voluntary labeling
of bioengineered food be restricted. Allowing only certified organic food to
be voluntarily labeled as "non-GMO" would placate the most vocal propo-
nents of such labeling while having a minimal adverse impact on the overall
food industry. Manufacturers wishing to exploit the emerging "non-GMO"
market trend could do so by complying with the standards set for certified
organic foods. By restricting such labeling to the organic food segment, the
potential problem of constructive labeling as being bioengineered by impli-
cation can be avoided; all organic foods are by definition free of bioengi-
neered material. Manufacturers wishing to continue using bioengineered
food ingredients could do so without fear of negative marketing. And con-
sumers desiring foods free of bioengineered material could purchase certi-
fied organic food with the voluntary "non-GMO" label. This approach
would be a win-win situation for both advocates and opponents of bioengi-
neered food.
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